DURHAM, N.C., Sept. 21, 2010 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp (OTCBB:CURX), today commented on significant new research in the search for an effective treatment for those suffering from Alzheimer’s disease. The research titled “The Alzheimer’s Disease –Associated Amyloid B-Protein Is an Antimicrobial Peptide,” was published by PLoS ONE, an international, on-line publication.
